Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in ...
Perry Halkitis’ new book argues public health leaders need to better understand human behavior in outbreaks ...